1 |
Barbara Alicja jereczek-Fossa MD, PhD Marco Krengli MD, Roberto Orecchia MD, "Particle beam radiotherapy for head and neck tumors: Radiobiological basis and clinical experience", HEAD&NECK, Vol. 28, pp.750-760, 2006
|
2 |
Paola Scampoli, "Biological effects of accelerated protons", Heavy Charged Particles in Biology and Medecine, Vol. 73, pp.S130-S133, 2004.
|
3 |
김대용, 박성용, Proton Beam Therapy, 대한의사협회지, Vol. 51, No. 7, pp.638-642, 2008.
|
4 |
Xuan Phuc Nguyen, ""Iron oxide-based conjugates for cancer theragnostics"", IOP Science, Vol. 3, pp.13, 2012.
|
5 |
Van Meir, E. G.; Hadjipanayis, C. G.; Norden, A. D.; Shu, H. K.; Wen, P. Y.; Olson, J. J. "Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma". CA: A Cancer Journal for Clinicians Vol. 60, No. 3, pp. 166-193, 2010
DOI
ScienceOn
|
6 |
W.Rueter, A.Lurio, E.Cardone and J.F.Ziegler, J. of Applied Physics, Vol. 46, pp.3194, 1975.
DOI
ScienceOn
|
7 |
Jong-Ki Kim, Seung-Jin Seo, Ki-Hong Kim, Tae-Jeong Kim, Myung-Hwan Chung, Kye-Ryung Kim, and Tae-Keun Yang, "Therapeutic application of metallic nanoparticles combined with particle-induced x-ray emission effect", Nanotechnology Vol. 21 pp.425102-425112, 2010
DOI
ScienceOn
|
8 |
Berridge MV, Tan As, "Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction", Archives of Biochemistry and Biophysics, Vol. 303, pp.474-482, 1993.
DOI
ScienceOn
|
9 |
http://mc50.kirams.re.kr
|
10 |
JM Hillegass, "Assessing nanotoxicity in cells in vitro", Wiley Interdiscip Rev Nanomed Nanobiotechnol, Vol. 2, pp.219-231, 2010.
DOI
|
11 |
KM Prise, G Schettino, M Folkard, KD Held, "New insights on cell death from radiation exposure", The Lancet Oncology, Vol. 6, pp.520-528, 2005
DOI
ScienceOn
|